Direct Electron Detector Patents: Filing Trends and Who Holds the Ground
Concentrated but not locked down. the top 5 assignees hold 21.4% of all 1,435 records in scope, and the top 10 hold 34.6% — a leader well ahead of a long tail of single- and double-digit filers. Annual filings rose from 29 in 2017 to a peak of 225 in 2023. Comparing 2021 (170) to 2024 (150) — the most recent year that can be treated as complete — filings are down 12% over that span; 2025 and 2026 figures will continue to fill in as publication catches up, so they should not yet be read as a further decline.
- 1RGT UNIV OF CALIFORNIA78
- 2BOARD OF RGT THE UNIV OF TEXAS SYST73
- 3UNITED KINGDOM RESEARCH AND INNOVATION59
- 4VLAAMS INTERUNIVERSITAIR INST VOOR BIOTECHNOLOGIE VZW52
- 5VRIJE UNIV BRUSSEL45
See the full direct electron detectors analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions about direct electron detector patents
Who holds the most direct electron detector patents?
The ranked leaders in this dataset are dominated by public university systems and research consortia rather than a single instrument manufacturer, with the top-ranked assignee holding 78 records out of 1,435 in scope. The top 5 assignees combined hold 21.4% of all records and the top 10 hold 34.6%, which leaves nearly two-thirds of filings spread across a long tail of smaller and single-filing entrants. This pattern suggests the underlying science is still substantially academic, with licensing and spin-outs following rather than leading the patent activity.
Is direct electron detector patent filing still growing?
Filings rose steadily from 29 in 2017 to a peak of 225 in 2023, but comparing 2021 (170) to 2024 (150) — the two most recent years that can be treated as complete — shows a 12% decline. The 2025 and 2026 figures in any trend chart will look lower still, but that is a publication-lag artefact rather than evidence of a further drop, since publication typically lags actual filing by about 18 months. Treat 2024 as the most recent reliable data point until later years catch up.
What technology areas overlap most with direct electron detector patents?
The IPC composition shows peptide and protein chemistry (C07K, 42.0% of records) and medicinal preparations (A61K, 40.8%) as the largest classes, ahead of therapeutic-activity claims (A61P, 25.9%) and microorganism/genetic-engineering claims (C12N, 19.7%). Electron and discharge tube hardware (H01J), the class closest to the detector itself, covers only 13.2% of records. This means most filings in the set pair detector-related language with a specific biological or diagnostic application rather than claiming detector hardware in isolation.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Direct Electron Detectors covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.